Breast Cancer is the leading cause of cancer in women. It is well-established that early diagnosis is very critical in saving a life of a cancer patient. Co-founded by Geetha Manjunath and Nidhi Mathur, researchers at NIRAMAI have developed a new cancer screening software that uses machine intelligence over thermography images to enable a low cost, easy to use, portable solution and requires minimal human supervision. NIRAMAI solution uses a high resolution thermal sensing device and cloud hosted analytics solution for analysing the thermal images. The SaaS solution uses big data analytics, artificial intelligence and machine learning for reliable, early and accurate breast cancer screening. The innovative methods used in the solution have led to multiple US patents.
Diverse and Global experience across Technology & Investments
Our core team brings decades of operating experience in building disruptive technology companies, business strategy, and global investments. While we bring diverse perspectives, we are bound by a shared passion for backing bold entrepreneurs in DeepTech. We believe in conviction-led investing and supporting our founders throughout their journey.
immunitoAI is developing an AI-powered platform for antibody discovery and screening. The platform screens and ranks the best antibody candidates for a given target/antigen. With this technology, the discovery process can be made 2x more efficient while improving the success rate.
Insane AI is an AI powered fitness app which leverages computer vision on the mobile phone to create personalized workouts at home. It makes workouts fun and engaging using immersive gamification routines.
LimeChat was founded in 2020 amid a pandemic-induced surge in adoption of e-commerce in India. The chatbot offers conversational experiences to customers on platforms including WhatsApp and Facebook Messenger.